Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Apr 22 03:23PM ET
92.06
Dollar change
+5.21
Percentage change
5.99
%
IndexRUT P/E- EPS (ttm)-8.37 Insider Own2.33% Shs Outstand61.15M Perf Week8.07%
Market Cap5.64B Forward P/E- EPS next Y-2.82 Insider Trans-11.99% Shs Float59.80M Perf Month2.23%
Income-506.98M PEG- EPS next Q-1.67 Inst Own106.34% Short Float7.31% Perf Quarter10.88%
Sales249.38M P/S22.60 EPS this Y33.13% Inst Trans-2.82% Short Ratio5.62 Perf Half Y99.86%
Book/sh2.14 P/B43.10 EPS next Y49.61% ROA-42.26% Short Interest4.37M Perf Year91.14%
Cash/sh11.61 P/C7.93 EPS next 5Y- ROE-157.13% 52W Range43.89 - 101.00 Perf YTD-0.20%
Dividend Est.- P/FCF- EPS past 5Y-9.19% ROI-61.58% 52W High-8.86% Beta0.67
Dividend TTM- Quick Ratio3.66 Sales past 5Y220.20% Gross Margin87.46% 52W Low109.74% ATR (14)4.32
Dividend Ex-Date- Current Ratio3.76 EPS Y/Y TTM10.38% Oper. Margin-194.99% RSI (14)54.50 Volatility4.82% 4.26%
Employees655 Debt/Eq5.93 Sales Y/Y TTM22.22% Profit Margin-203.30% Recom1.88 Target Price97.38
Option/ShortYes / Yes LT Debt/Eq5.30 EPS Q/Q31.25% Payout- Rel Volume0.65 Prev Close86.85
Sales Surprise7.21% EPS Surprise10.77% Sales Q/Q85.55% EarningsMay 02 BMO Avg Volume778.16K Price92.06
SMA201.93% SMA503.40% SMA20032.38% Trades Volume457,870 Change5.99%
Date Action Analyst Rating Change Price Target Change
Oct-27-23Upgrade Oppenheimer Perform → Outperform $85
Aug-21-23Reiterated Needham Buy $65 → $66
Jul-31-23Upgrade Wells Fargo Equal Weight → Overweight $55 → $82
Jun-05-23Downgrade SVB Securities Market Perform → Underperform $48 → $43
Jan-03-23Upgrade Wells Fargo Underweight → Equal Weight $41
Dec-14-22Initiated Needham Buy $60
Nov-02-22Downgrade Oppenheimer Outperform → Perform
Sep-14-22Initiated Berenberg Buy $90
Jul-08-22Initiated Oppenheimer Outperform $80
Jun-27-22Initiated Wells Fargo Underweight $40
Apr-18-24 08:00AM
Apr-11-24 08:00AM
Apr-04-24 04:01PM
Mar-28-24 08:13AM
Mar-17-24 08:50AM
07:00PM Loading…
Mar-15-24 07:00PM
Mar-06-24 04:01PM
11:53AM
Feb-23-24 08:00AM
Feb-16-24 03:30PM
09:37AM
05:47AM
Feb-15-24 10:50PM
10:55AM
08:25AM
07:43AM Loading…
07:43AM
07:26AM
07:00AM
07:00AM
Feb-12-24 09:16AM
Feb-08-24 10:00AM
Feb-05-24 04:01PM
Feb-01-24 08:00AM
Jan-16-24 12:00PM
11:51AM
Jan-09-24 01:51PM
Jan-08-24 08:00AM
Jan-05-24 04:01PM
Dec-18-23 08:00AM
Dec-14-23 11:05AM
08:05AM Loading…
Dec-12-23 08:05AM
Dec-10-23 11:59AM
Dec-09-23 12:30PM
Dec-04-23 04:01PM
Nov-28-23 08:00AM
Nov-14-23 05:05PM
Nov-13-23 04:29PM
Nov-10-23 08:00AM
Nov-04-23 03:02AM
Nov-03-23 04:01PM
Oct-31-23 09:55AM
09:40AM
03:48AM
Oct-30-23 03:46PM
Oct-28-23 01:49PM
Oct-27-23 10:01AM
07:27AM
Oct-26-23 11:42PM
05:47PM
09:30AM
08:52AM
08:15AM
07:09AM
07:00AM
Oct-25-23 10:15AM
Oct-23-23 08:30AM
Oct-20-23 10:00AM
Oct-19-23 10:01AM
Oct-12-23 08:00AM
Oct-06-23 03:00AM
Oct-05-23 04:01PM
Sep-29-23 11:01PM
Sep-08-23 11:30AM
Sep-07-23 11:30AM
Sep-05-23 04:01PM
Sep-01-23 11:31AM
Aug-04-23 04:16PM
Aug-02-23 01:00PM
12:42PM
09:30AM
08:25AM
07:14AM
07:00AM
Jul-19-23 08:00AM
Jul-14-23 11:53AM
Jul-05-23 04:30PM
Jun-30-23 08:56AM
06:26AM
Jun-12-23 09:30AM
Jun-09-23 09:22AM
Jun-05-23 05:00PM
Jun-04-23 08:45AM
Jun-03-23 09:00AM
May-23-23 10:00AM
May-22-23 04:04PM
May-05-23 06:54AM
May-04-23 05:01PM
08:25AM
07:25AM
07:00AM
May-01-23 10:01AM
Apr-27-23 10:02AM
Apr-26-23 10:00AM
Apr-20-23 04:01PM
Apr-19-23 08:07AM
Apr-11-23 08:00AM
Apr-05-23 04:01PM
Mar-31-23 11:30AM
Mar-29-23 08:31AM
Mar-28-23 04:05PM
Blueprint Medicines Corp. is a precision therapy company, which engages in the invention of medicines for people with cancer and blood disorders. The company was founded by Chris Varma, Nicholas B. Lydon, Brian Druker, and Alexis Borisy on October 14, 2008 and is headquartered in Cambridge, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Landsittel MichaelCHIEF FINANCIAL OFFICERMar 28 '24Option Exercise36.055,000180,25052,286Apr 01 04:34 PM
Landsittel MichaelCHIEF FINANCIAL OFFICERMar 28 '24Sale95.005,000475,00047,286Apr 01 04:34 PM
Albers Jeffrey W.DirectorMar 20 '24Option Exercise7.1125,073178,287201,123Mar 22 05:50 PM
Albers Jeffrey W.DirectorMar 20 '24Sale87.2825,0732,188,264176,050Mar 22 05:50 PM
Landsittel MichaelCHIEF FINANCIAL OFFICERMar 15 '24Option Exercise36.055,000180,25061,020Mar 19 05:11 PM
Hurley ArielPRINCIPAL ACCOUNTING OFFICERMar 15 '24Option Exercise15.011,60024,01618,662Mar 19 04:48 PM
Landsittel MichaelCHIEF FINANCIAL OFFICERMar 15 '24Sale87.7813,7341,205,60647,286Mar 19 05:11 PM
Hurley ArielPRINCIPAL ACCOUNTING OFFICERMar 15 '24Sale87.764,549399,21314,913Mar 19 04:48 PM
Lee PhilinaCHIEF COMMERCIAL OFFICERMar 13 '24Option Exercise13.151,74722,97542,752Mar 15 04:47 PM
Lee PhilinaCHIEF COMMERCIAL OFFICERMar 13 '24Sale90.408,023725,27734,729Mar 15 04:47 PM
Haviland KateCHIEF EXECUTIVE OFFICERMar 07 '24Sale90.6912,4641,130,360153,177Mar 11 06:27 PM
Albers Jeffrey W.DirectorMar 07 '24Sale90.6911,0331,000,583165,017Mar 26 09:11 PM
Rossi ChristinaCHIEF OPERATING OFFICERMar 07 '24Sale90.696,070550,48864,306Mar 11 06:21 PM
McCain Tracey LEVP AND CHIEF LEGAL OFFICERMar 07 '24Sale90.695,194471,04460,498Mar 11 06:18 PM
Durso-Bumpus DebraCHIEF PEOPLE OFFICERMar 07 '24Sale90.695,093461,88457,585Mar 11 06:28 PM
Landsittel MichaelCHIEF FINANCIAL OFFICERMar 07 '24Sale90.695,003453,72256,020Mar 11 06:23 PM
Namouni FouadPRESIDENT, R & DMar 07 '24Sale90.694,377396,95072,703Mar 11 06:20 PM
Hewes L. BeckerCHIEF MEDICAL OFFICERMar 07 '24Sale90.693,097280,86746,281Mar 11 06:29 PM
Lee PhilinaCHIEF COMMERCIAL OFFICERMar 07 '24Sale90.692,934266,08441,005Mar 11 06:26 PM
Murray Christopher K.CHIEF TECHNICAL OPERATIONSMar 07 '24Sale90.692,521228,62933,853Mar 11 06:24 PM
Carter Percy H.CHIEF SCIENTIFIC OFFICERMar 07 '24Sale90.692,286207,31748,331Mar 11 06:19 PM
Hurley ArielPRINCIPAL ACCOUNTING OFFICERMar 07 '24Sale90.691,462132,58917,862Mar 11 06:15 PM
Murray Christopher K.CHIEF TECHNICAL OPERATIONSMar 04 '24Sale93.6562158,15736,374Mar 06 10:41 AM
Murray Christopher K.CHIEF TECHNICAL OPERATIONSFeb 28 '24Option Exercise54.135,000270,65029,495Mar 01 03:06 PM
Murray Christopher K.CHIEF TECHNICAL OPERATIONSFeb 28 '24Sale100.005,000500,00024,495Mar 01 03:06 PM
Albers Jeffrey W.DirectorJan 25 '24Option Exercise7.1325,000178,150201,050Jan 29 06:13 PM
Albers Jeffrey W.DirectorJan 25 '24Sale81.9125,0002,047,800176,050Jan 29 06:13 PM
Hurley ArielPRINCIPAL ACCOUNTING OFFICERDec 22 '23Option Exercise8.807146,28315,038Dec 26 04:24 PM
Hurley ArielPRINCIPAL ACCOUNTING OFFICERDec 22 '23Sale90.0071464,26014,324Dec 26 04:24 PM
Hurley ArielPRINCIPAL ACCOUNTING OFFICERDec 15 '23Option Exercise1.873,6546,83316,411Dec 19 04:05 PM
Hurley ArielPRINCIPAL ACCOUNTING OFFICERDec 15 '23Sale84.353,914330,14614,324Dec 19 04:05 PM
Lee PhilinaCHIEF COMMERCIAL OFFICERDec 13 '23Option Exercise1.8726148831,439Feb 14 06:54 PM
Albers Jeffrey W.DirectorDec 11 '23Option Exercise36.055,000180,250181,050Dec 13 03:56 PM
Albers Jeffrey W.DirectorDec 11 '23Sale79.075,000395,350176,050Dec 13 03:56 PM
Murray Christopher K.CHIEF TECHNICAL OPERATIONSDec 07 '23Option Exercise54.135,000270,65029,495Dec 11 05:11 PM
Murray Christopher K.CHIEF TECHNICAL OPERATIONSDec 07 '23Sale75.005,000375,00024,495Dec 11 05:11 PM
Murray Christopher K.CHIEF TECHNICAL OPERATIONSDec 04 '23Sale71.4360042,85824,495Dec 06 08:45 PM
Albers Jeffrey W.DirectorNov 30 '23Option Exercise36.055,000180,250181,050Dec 04 04:02 PM
Albers Jeffrey W.DirectorNov 30 '23Sale70.555,000352,750176,050Dec 04 04:02 PM
Albers Jeffrey W.DirectorNov 24 '23Option Exercise1.8715,00028,050191,050Nov 28 04:05 PM
Albers Jeffrey W.DirectorNov 24 '23Sale67.5115,0001,012,690176,050Nov 28 04:05 PM
Albers Jeffrey W.DirectorNov 03 '23Option Exercise36.051,48553,534177,535Nov 03 05:07 PM
Albers Jeffrey W.DirectorNov 03 '23Sale60.131,48589,293176,050Nov 03 05:07 PM
Albers Jeffrey W.DirectorNov 02 '23Option Exercise36.054,634167,056180,684Nov 03 05:07 PM
Albers Jeffrey W.DirectorNov 02 '23Sale60.374,634279,749176,050Nov 03 05:07 PM
Albers Jeffrey W.DirectorNov 01 '23Option Exercise36.053,881139,910179,931Nov 03 05:07 PM
Albers Jeffrey W.DirectorNov 01 '23Sale60.023,881232,938176,050Nov 03 05:07 PM
Murray Christopher K.CHIEF TECHNICAL OPERATIONSOct 26 '23Sale56.4060033,84025,095Oct 30 02:01 PM
Namouni FouadPRESIDENT, R & DOct 04 '23Sale48.063,769181,13862,080Oct 05 10:47 AM
Albers Jeffrey W.DirectorSep 28 '23Option Exercise1.876,89812,899182,948Sep 29 02:36 PM
Albers Jeffrey W.DirectorSep 28 '23Sale50.176,898346,073176,050Sep 29 02:36 PM
Albers Jeffrey W.DirectorSep 27 '23Option Exercise1.8718,10233,851194,152Sep 29 02:36 PM
Albers Jeffrey W.DirectorSep 27 '23Sale49.6118,102897,957176,050Sep 29 02:36 PM
Albers Jeffrey W.DirectorAug 25 '23Option Exercise1.8710,00018,700186,050Aug 28 06:23 PM
Albers Jeffrey W.DirectorAug 25 '23Sale50.1610,000501,600176,050Aug 28 06:23 PM
Albers Jeffrey W.DirectorAug 24 '23Option Exercise1.8715,00028,050191,050Aug 28 06:23 PM
Albers Jeffrey W.DirectorAug 24 '23Sale49.5715,000743,550176,050Aug 28 06:23 PM
Carter Percy H.CHIEF SCIENTIFIC OFFICERJun 05 '23Sale52.062,307120,10238,117Jun 07 07:52 PM
Hewes L. BeckerCHIEF MEDICAL OFFICERJun 05 '23Sale52.051,40473,07836,878Jun 07 07:48 PM